Strattera 60Mg 28Cap

Strattera 60Mg 28Cap

Description:

Strattera 60 mg 28 capsules is a prescription medicine used for the treatment of attention-deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It contains atomoxetine, the first non-stimulant drug approved for ADHD, which works by selectively inhibiting the reuptake of norepinephrine in the brain. Unlike stimulant medications, Strattera is not an amphetamine and has a lower risk of abuse or dependence. It is typically used as part of a comprehensive treatment program that may include psychological, educational, and social measures to improve attention, reduce hyperactivity, and control impulsive behavior.

Indications:

• Treatment of attention-deficit hyperactivity disorder (ADHD) in children, adolescents, and adults.
• Helps improve attention span and concentration.
• Reduces symptoms of hyperactivity and impulsivity.
• Supports better control of behavior and academic or work performance when used as part of a comprehensive ADHD management plan.

Active Ingredients / Key Components:

• Atomoxetine hydrochloride – 60 mg per capsule (active ingredient).
• Other inactive ingredients (excipients) are present in the capsule formulation, but detailed excipient list and their concentrations , please check the product leaflet or the manufacturer’s official website.

Dosage & Administration / How to Use:

• Strattera is for oral use only and should be swallowed whole with water. Do not open, crush, or chew the capsules.
• It may be taken with or without food, preferably at the same time each day.
• Dosing in children and adolescents up to 70 kg body weight:
  - Initial dose: 0.5 mg/kg/day.
  - After a minimum of 3 days, increase to a target total daily dose of approximately 1.2 mg/kg/day.
  - The total daily dose can be administered as a single morning dose or divided into two doses (morning and late afternoon/early evening).
  - Maximum total daily dose: 1.4 mg/kg/day or 100 mg (whichever is lower).
• Dosing in children and adolescents over 70 kg body weight and adults:
  - Initial dose: 40 mg/day.
  - After a minimum of 3 days, increase to a target total daily dose of approximately 80 mg/day.
  - The total daily dose can be given as a single morning dose or divided into two doses (morning and late afternoon/early evening).
  - Maximum total daily dose: 100 mg/day.
• Dosing must always be individualized and determined by the treating physician based on age, body weight, response, and tolerability.
• Do not change the dose or stop taking Strattera without consulting your doctor.

Clinical Benefits:

• Provides effective non-stimulant treatment for ADHD symptoms in children, adolescents, and adults.
• Improves attention, focus, and ability to concentrate over the day.
• Reduces hyperactivity and impulsive behavior, supporting better self-control.
• Offers an alternative for patients who cannot tolerate or should not use stimulant medications.
• Lower potential for abuse and dependence compared with stimulant ADHD medications.

Warnings & Contraindications:

• Use only under medical supervision and on prescription.
• Contraindicated in patients with hypersensitivity to atomoxetine or any component of the product.
• Contraindicated in patients with narrow-angle glaucoma.
• Contraindicated in patients who have taken monoamine oxidase inhibitors (MAOIs) within the last 14 days due to risk of serious interactions.
• Use with caution in patients with cardiovascular disorders (e.g., hypertension, tachycardia, heart disease) or cerebrovascular conditions; blood pressure and heart rate should be monitored regularly.
• Use with caution in patients with liver impairment; dose adjustment may be required.
• May increase risk of suicidal thoughts in children and adolescents, especially at the beginning of treatment or after dose changes; close monitoring is essential.
• May cause growth delay in some children; growth (height and weight) should be monitored during long-term treatment.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Use only if the potential benefit justifies the potential risk.
• May cause dizziness, fatigue, or sleep disturbances; caution is advised when driving or operating machinery until you know how the medicine affects you.
• Do not use with other medicines that significantly affect norepinephrine without medical advice.
• Consult your doctor before use if you have liver disease, cardiovascular disease, psychiatric disorders (e.g., depression, bipolar disorder), or a history of seizures.
• Keep out of reach of children.
• Not intended to diagnose, treat, cure, or prevent any disease outside the approved indication for ADHD.

Side Effects:

• Common side effects: decreased appetite, nausea, vomiting, stomach pain, dry mouth, constipation, dizziness, fatigue, sleepiness or insomnia, headache, increased heart rate, and mild increase in blood pressure.
• Less common side effects: mood changes, irritability, urinary difficulties, sexual side effects (in adults), sweating, and weight loss.
• Serious side effects (seek immediate medical attention): signs of liver problems (itching, dark urine, yellowing of skin or eyes, right upper abdominal pain), severe allergic reactions (rash, swelling of face or throat, difficulty breathing), severe chest pain, unexplained fainting, or new/worsening suicidal thoughts or behavior.
• If any side effect is severe, persistent, or concerning, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date stated on the package. Store at room temperature according to the manufacturer’s recommendations (exact temperature range not provided in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.)).

Specifications:

• Form: Capsules.
• Strength: 60 mg atomoxetine per capsule.
• Pack size: 28 capsules per pack.
• Route of administration: Oral.
• Intended for: Children, adolescents, and adults diagnosed with ADHD, under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.